Q3 2025 revenue of €143.1 million for YORVIPATH® and €50.7 million for SKYTROFA®– Q3 2025 operating profit of €11.0 million– TransCon® ...
This week, the White House announced a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1 weight loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback